Many Investors Still Treating Gilead: 4 Launches This Year Could Prove Them Wrong
Gilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Paying off credit card debt can be easier with dividends. Learn how to utilize your investment earnings for debt repayment.
21,598 articlesGilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
A major institutional purchase has put Enviri in the spotlight. This article breaks down what the $43 million buy mea...
In early 2026, Tutor Perini faced a mix of growth opportunities and project-level headwinds. This article breaks down...
A smaller e-commerce stock jumped 25% in 2026, outpacing Amazon’s gains. This guide explains what’s driving the move,...
If you’re nearing retirement, it’s smart to pause and assess. Here are five telltale signs you might want to wait, pl...
Hovnanian Enterprises reports a profit for Q1 2026 as it shifts focus to higher-margin homes. The move aims to lift m...
Vericel faces a pivotal 2026 earnings season. This guide breaks down the drivers behind the numbers, what to watch in...
New American Funding is expanding its reverse mortgage team to turn home equity into a core retirement tool, led by S...
A single family moment can reveal big money lessons. This article turns a pop culture moment into actionable steps fo...
Investors chasing reliable profits often look for markets with strong rent demand and balanced growth. This article b...
SpaceX IPO excitement can tempt any investor, but the space sector is risky and competitive. This guide compares Spac...
A Federal Reserve governor's message carries big weight for markets. This piece breaks down the implications of words...